InterMed and Axxam continue partnership

InterMed Discovery, a natural product lead-discovery company, and Axxam SpA, a gene-to-lead biotechnology company, have signed a second partnership agreement to further combine the platforms of the two companies.

March 11, 2009

InterMed Discovery, a natural product lead-discovery company, and Axxam SpA, a gene-to-lead biotechnology company, have signed a second partnership agreement to further combine the platforms of the two companies. Their first partnership proved to be successful in providing a technology platform that offers, in addition to screening solutions, the discovery of natural bioactive compounds that can be used in the food and beverage industries. The new joint research will focus on the mutual discovery and validation of flavor and fragrance functional ingredients, which will then be offered to food, beverages, flavor, and fragrance companies.

“This cooperation is a direct response to what we see as growing market needs,” said Thomas Henkel, Managing Director, InterMed Discovery. “Our innovative approach to developing natural functional ingredients together with Axxam caters perfectly to the increasing market demand for turnkey solutions.”

Release

Story Tools